{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:00:51Z","timestamp":1790722851287,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"vor","delay-in-days":731,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005261","name":"CHU Montpellier","doi-asserted-by":"publisher","award":["2007-A00216-47"],"award-info":[{"award-number":["2007-A00216-47"]}],"id":[{"id":"10.13039\/501100005261","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Vaincre La Mucoviscidose"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cysticfibrosisjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jcf.2015.02.012","type":"journal-article","created":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T07:10:40Z","timestamp":1427440240000},"page":"646-653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Should diffuse bronchiectasis still be considered a CFTR-related disorder?"],"prefix":"10.1016","volume":"14","author":[{"given":"Anne","family":"Bergougnoux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Viart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Miro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7288-3573","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Bommart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Molinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"des Georges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Claustres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Chiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Taulan-Cadars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8701","key":"10.1016\/j.jcf.2015.02.012_bb0005","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/0140-6736(90)91216-W","article-title":"Abnormal distribution of cystic fibrosis delta F508 allele in adults with chronic bronchial hypersecretion","volume":"335","author":"Dumur","year":"1990","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.jcf.2015.02.012_bb0010","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF01649427","article-title":"Sequence analysis of the cystic fibrosis gene in patients with disseminated bronchiectatic lung disease. Application in the identification of a cystic fibrosis patient with atypical clinical course","volume":"69","author":"Poller","year":"1991","journal-title":"Klin Wochenschr"},{"issue":"8877","key":"10.1016\/j.jcf.2015.02.012_bb0015","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/0140-6736(93)92046-V","article-title":"Sweat chloride and delta F508 mutation in chronic bronchitis or bronchiectasis","volume":"342","author":"Gervais","year":"1993","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jcf.2015.02.012_bb0020","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1164\/rccm.200909-1434OC","article-title":"Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis","volume":"181","author":"Bienvenu","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.jcf.2015.02.012_bb0025","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s004390050897","article-title":"Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease","volume":"103","author":"Bombieri","year":"1998","journal-title":"Hum Genet"},{"issue":"3","key":"10.1016\/j.jcf.2015.02.012_bb0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000484750","article-title":"CFTR gene mutations in adults with disseminated bronchiectasis","volume":"5","author":"Girodon","year":"1997","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.1016\/j.jcf.2015.02.012_bb0035","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s004390100467","article-title":"CFTR gene mutations\u2013including three novel nucleotide substitutions\u2013and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease","volume":"108","author":"Tzetis","year":"2001","journal-title":"Hum Genet"},{"issue":"6","key":"10.1016\/j.jcf.2015.02.012_bb0040","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.0009-9163.2004.00265.x","article-title":"Bronchiectasis in adult patients: an expression of heterozygosity for CFTR gene mutations?","volume":"65","author":"Casals","year":"2004","journal-title":"Clin Genet"},{"issue":"5","key":"10.1016\/j.jcf.2015.02.012_bb0045","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2353\/jmoldx.2007.070040","article-title":"Comprehensive and rapid genotyping of mutations and haplotypes in congenital bilateral absence of the vas deferens and other cystic fibrosis transmembrane conductance regulator-related disorders","volume":"9","author":"Bareil","year":"2007","journal-title":"J Mol Diagn"},{"issue":"2","key":"10.1016\/j.jcf.2015.02.012_bb0050","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1098-1004(1997)10:2<135::AID-HUMU6>3.0.CO;2-J","article-title":"Geographic distribution and regional origin of 272 cystic fibrosis mutations in European populations. The Biomed CF mutation analysis consortium","volume":"10","author":"Estivill","year":"1997","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.jcf.2015.02.012_bb0055","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/humu.9158","article-title":"Comparison of the CFTR mutation spectrum in three cohorts of patients of Celtic origin from Brittany (France) and Ireland","volume":"22","author":"Scotet","year":"2003","journal-title":"Hum Mutat"},{"issue":"9","key":"10.1016\/j.jcf.2015.02.012_bb0060","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1093\/nar\/gkp215","article-title":"Human Splicing Finder: an online bioinformatics tool to predict splicing signals","volume":"37","author":"Desmet","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.jcf.2015.02.012_bb0065","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ejhg.2011.161","article-title":"Functional analysis of a promoter variant identified in the CFTR gene in cis of a frameshift mutation","volume":"20","author":"Viart","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jcf.2015.02.012_bb0070","article-title":"Transcription factors and miRNAs that regulate fetal to adult CFTR expression change are new targets for cystic fibrosis","author":"Viart","year":"2014","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.jcf.2015.02.012_bb0075","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jmg.2010.081851","article-title":"Variants in CFTR untranslated regions are associated with congenital bilateral absence of the vas deferens","volume":"48","author":"Lopez","year":"2011","journal-title":"J Med Genet"},{"issue":"9","key":"10.1016\/j.jcf.2015.02.012_bb0080","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/humu.21316","article-title":"UMD-CFTR: a database dedicated to CF and CFTR-related disorders","volume":"31","author":"Bareil","year":"2010","journal-title":"Hum Mutat"},{"issue":"11","key":"10.1016\/j.jcf.2015.02.012_bb0085","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/humu.22129","article-title":"CFTR mutation combinations producing frequent complex alleles with different clinical and functional outcomes","volume":"33","author":"El-Seedy","year":"2012","journal-title":"Hum Mutat"},{"issue":"1","key":"10.1016\/j.jcf.2015.02.012_bb0090","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ejhg.2010.137","article-title":"p.Ser1235Arg should no longer be considered as a cystic fibrosis mutation: results from a large collaborative study","volume":"19","author":"Ren\u00e9","year":"2011","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"10.1016\/j.jcf.2015.02.012_bb0095","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/hmg\/ddg131","article-title":"New type of disease causing mutations: the example of the composite exonic regulatory elements of splicing in CFTR exon 12","volume":"12","author":"Pagani","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"16","key":"10.1016\/j.jcf.2015.02.012_bb0100","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/hmg\/ddg215","article-title":"Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene","volume":"12","author":"Aznarez","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"41","key":"10.1016\/j.jcf.2015.02.012_bb0105","doi-asserted-by":"crossref","first-page":"25710","DOI":"10.1016\/S0021-9258(18)47306-1","article-title":"Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins","volume":"269","author":"Ward","year":"1994","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.jcf.2015.02.012_bb0110","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ng.2745","article-title":"Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene","volume":"45","author":"Sosnay","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.jcf.2015.02.012_bb0115","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1089\/ped.2013.0238","article-title":"Analysis of CFTR gene variants in idiopathic bronchiectasis in Serbian children","volume":"26","author":"Milosevic","year":"2013","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"issue":"4","key":"10.1016\/j.jcf.2015.02.012_bb0120","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jcf.2014.05.007","article-title":"CFTR functional measurements in human models for diagnosis, prognosis and personalized therapy: report on the pre-conference meeting to the 11th ECFS Basic Science Conference, Malta, 26\u201329 March 2014","volume":"13","author":"Beekman","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"6","key":"10.1016\/j.jcf.2015.02.012_bb0125","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1165\/rcmb.2008-0018OC","article-title":"Functional properties of mixed cystic fibrosis and normal bronchial epithelial cell cultures","volume":"40","author":"Dannhoffer","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"10.1016\/j.jcf.2015.02.012_bb0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jcf.2013.09.007","article-title":"Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data","volume":"13","author":"Accurso","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"11","key":"10.1016\/j.jcf.2015.02.012_bb0135","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/rccm.201304-0733OC","article-title":"Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function","volume":"188","author":"Raju","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.jcf.2015.02.012_bb0140","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200508-1330OC","article-title":"Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers","volume":"173","author":"Cantin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcf.2015.02.012_bb0145","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1096\/fj.11-192377","article-title":"Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration","volume":"26","author":"Clunes","year":"2012","journal-title":"FASEB J"},{"issue":"10","key":"10.1016\/j.jcf.2015.02.012_bb0150","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/humu.22382","article-title":"Characterization of SLC26A9 in patients with CF-like lung disease","volume":"34","author":"Bakouh","year":"2013","journal-title":"Hum Mutat"},{"issue":"3","key":"10.1016\/j.jcf.2015.02.012_bb0155","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ng.535","article-title":"Variants in FAM13A are associated with chronic obstructive pulmonary disease","volume":"42","author":"Cho","year":"2010","journal-title":"Nat Genet"},{"issue":"13","key":"10.1016\/j.jcf.2015.02.012_bb0160","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa0906312","article-title":"A large-scale, consortium-based genomewide association study of asthma","volume":"363","author":"Moffatt","year":"2010","journal-title":"N Engl J Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199315000545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199315000545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T22:22:33Z","timestamp":1651616553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199315000545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1569199315000545"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2015.02.012","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should diffuse bronchiectasis still be considered a CFTR-related disorder?","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2015.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}